3 ms·

CBS say this then don't publish the data! The data [https://www.transonic.com/renal-disease-in-us https://www.transonic.com/renal-disease-in-us] says that kidn

CBS say this then don't publish the data! The data [https://www.transonic.com/renal-disease-in-us https://www.transonic.com/renal-disease-in-us] says that kidney transplants for dialysis patients happen LESS frequently in the USA than in Europe, yet the survival rate is very close - 39% USA vs 41% Europe. This implies that dialysis in the USA is very close or _better_ quality than in Europe - as there is a large difference in transplant rates but only a small difference in survival rates. Maybe the above data is wrong, but CBS don't seem to provide any better data

hermanzegerman 9mo ago
Your own link says Survival rates for ESRD are higher in Europe than the U.S. This could be explained by the inferiority of national standards of care, a higher prevalence of patients with diabetes and differences in practice patterns. Let's look at actual journals For those with ESKD onset from 2004 to 2008, unadjusted 5-year survival of all patients with ESKD (treated with dialysis or transplantation) was 41% in the USA, 48% in Europe, and 60% in Japan, despite patients being 2–3 years older on average in Europe and Japan than in the USA, and Japan having very few transplant patients. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30448-2/abstract https://www.thelancet.com/journals/lancet/article/PIIS0140-6... The US had a much higher KRT incidence, prevalence, and mortality compared to Europe, and despite a higher kidney transplantation rate, a lower proportion of prevalent patients with a functioning graft. https://pubmed.ncbi.nlm.nih.gov/38439701/ https://pubmed.ncbi.nlm.nih.gov/38439701/
- john-h-k 9mo ago
  This does seem like a direct contradiction to me, but it’s also 2 decades old
  - hermanzegerman 9mo ago
    The second paper has data from 2021, I've included the first one because it's from a top journal
    - john-h-k 9mo ago
      Then yeah, this supercedes my point, seems I am wrong

hermanzegerman 9mo ago

Your own link says Survival rates for ESRD are higher in Europe than the U.S. This could be explained by the inferiority of national standards of care, a higher prevalence of patients with diabetes and differences in practice patterns. Let's look at actual journals For those with ESKD onset from 2004 to 2008, unadjusted 5-year survival of all patients with ESKD (treated with dialysis or transplantation) was 41% in the USA, 48% in Europe, and 60% in Japan, despite patients being 2–3 years older on average in Europe and Japan than in the USA, and Japan having very few transplant patients. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30448-2/abstract https://www.thelancet.com/journals/lancet/article/PIIS0140-6... The US had a much higher KRT incidence, prevalence, and mortality compared to Europe, and despite a higher kidney transplantation rate, a lower proportion of prevalent patients with a functioning graft. https://pubmed.ncbi.nlm.nih.gov/38439701/ https://pubmed.ncbi.nlm.nih.gov/38439701/

john-h-k 9mo ago
This does seem like a direct contradiction to me, but it’s also 2 decades old
- hermanzegerman 9mo ago
  The second paper has data from 2021, I've included the first one because it's from a top journal
  - john-h-k 9mo ago
    Then yeah, this supercedes my point, seems I am wrong